Archive

Rebel Category: REBEL EM

COVID-19 and Anticoagulation: Full Dose or Prophylactic Dose?

Background: Patients with COVID-19 are at a high risk for the development of venous thromboembolic disease . Alveolar capillary microthrombi appear to be 9x more prevalent in patients with COVID-19 compared to H1N1. As a result, enhanced-dose anticoagulation ...

Read More
Hematology and Oncology

Rebellion in EM 2021: The History and Future of Emergency Medicine – The Evolution of Our Specialty

This was the opening keynote given at the Rebellion in EM 2021 Conference by Dr. Gillian Schmitz, MD. In this 25 minute talk, Dr. Schmitz discusses the history and future of Emergency Medicine.

Read More

The STROKE-AF and PER DIEM Trials: Detection of Atrial Fibrillation After Stroke

Background: The mainstays for management of stroke include admission to a stroke center and management of modifiable risk factors.1,2,3 It is estimated that most strokes are ischemic (87%),4 and atrial fibrillation and/or flutter are thought to be responsible for approximately ...

Read More
Neurology

TTM2: Hypothermia vs Normothermia for Out-of-Hospital Cardiac Arrest

Background Information: Hypothermia was first introduced in 2002 by two studies, Bernard et al and The Hypothermia After Cardiac Arrest (HACA) trial.1,2 The latter, although a small trial, showed improved neurologic outcomes at six months when patients were cooled to ...

Read More
CardiovascularNeurologyResuscitation

GRACE Guidelines: A Pragmatic Approach to Recurrent Low-Risk Chest Pain

In the United States, a patient with chest pain presents to the emergency department (ED) every 5 seconds. By the time you finish reading this post, 60 patients will have sought treatment for chest pain. In 2017, chest pain was ...

Read More
Cardiovascular
Showing Slide 1 of 6

Sponsored